CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Moberg Pharma AB (publ) Company Snapshot
Moberg Pharma AB (publ) operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Moberg Pharma AB (publ) with three other pharmaceutical manufacturers in Europe: Horizon Discovery Group PLC of the United Kingdom (2018 sales of £58.73 million [US$76.18 million] of which 79% was Products), New Nordic Healthbrands AB (393.71 million Swedish Kronor [US$40.83 million] ), and Venture Life Group plc which is based in the United Kingdom (£18.77 million [US$24.35 million] of which 65% was Development and Manufacturing).

Sales Analysis. Moberg Pharma AB (publ) reported sales of SEK 439.04 million (US$45.53 million) for the year ending December of 2018. This represents a very small increase of 0.0% versus 2017, when the company's sales were SEK 439.03 million. Sales at Moberg Pharma AB (publ) have increased during each of the previous five years (and since 2013, sales have increased a total of 179%). Sales of Dermoplast saw an increase that was more than double the company's growth rate: sales were up 22.2% in 2018, from SEK 96.59 million to SEK 117.98 million. Moberg Pharma AB (publ) also saw significant increases in sales in Kerasal Nail /nalox (up 14.5% to SEK 175.89 million) and New Skin (up 7.2% to SEK 94.11 million) . Not all segments of Moberg Pharma AB (publ) experienced an increase in sales in 2018: sales of Divested Products (Jointflex , Fergon , fell 76.1% to SEK 8.38 million. Moberg Pharma AB (publ) also experienced decreases in sales in Other Products (down 35.2% to SEK 42.68 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Moberg Pharma AB (publ)
  Stock Performance Chart for Moberg Pharma AB (publ)
 
  Stock Data: Recent Stock Performance:
  Current Price (10/18/2019): 76.50
(Figures in Swedish Kronor)
1 Week -0.5%   13 Weeks 18.2%  
4 Weeks 11.0%   52 Weeks 47.7%  
 
Moberg Pharma AB (publ) Key Data:
  Ticker: MOB Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2018 Sales 439,041,000
(Year Ending Jan 2019).
Employees: 37
  Currency: Swedish Kronor Market Cap: 1,390,759,214
  Fiscal Yr Ends: December Shares Outstanding: 18,179,859
  Share Type: Aktie Closely Held Shares: 5,576,410
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.